Los Angeles, March 01, 2016 -- Theradome Inc., creator of the most technologically advanced and powerful OTC hair restoration device, will be showcasing its wearable laser helmet for female hair loss at the American Academy of Dermatology’s 74th Annual Meeting at the Walter E. Washington Convention Center in in Washington, D.C., March 4 through 6 at booth #3161. The company will be providing live demonstrations of its Theradome Laser Helmet and will have units available for sale.
In its utilization of Laser Phototherapy (also known as Low-Level Laser Light Therapy), the Theradome LH80 PRO Laser Helmet stimulates weak hair follicles that contribute to balding and/or thinning hair in women and men for over 97 percent of patients. Worn twice a week for 20 minutes, the device boosts the mitochondria and ATP production of follicles, leading to hair regrowth.
“Already, our clinical studies have shown how impactful the Theradome Laser Helmet is as a hair loss treatment for women. Now, we are conducting even more research that we are confident will prove similar results in men,” said Tamim Hamid, former NASA scientist, CEO and Founder of Theradome. “As one of the most lauded educational events in the field, the American Academy of Dermatology’s Annual Meeting is an ideal place for us to introduce our innovative technology to doctors and experts whose patients will benefit most.”
Unlike most hair restoration procedures, products, and devices that have been used by dermatologists in the past, the Theradome LH80 PRO Laser Helmet is unique in that it offers powerful, side effect-free, convenient and clinically proven solution to hair loss that can be administered in the comfort of patients’ homes.
Each year, thousands of dermatology professionals from all over the country gather at the industry meeting for a weekend of networking and education. With hair loss continuing to be a major issue for many dermatology patients, Theradome Inc. is anticipated to be a key exhibitor at this year’s event.
For more information, please visit www.theradome.com.
About Theradome
Theradome™ is a medical therapy company located in Silicon Valley, Calif., focused on developing the world’s most technologically advanced Laser Phototherapy devices along with complementary, superior scalp products. The company is committed to restoring health and confidence in people all around the globe by bringing affordable, clinical strength hair rejuvenation therapies into the home. The products developed by Theradome can minimize shedding, thicken existing hair and promote new hair growth for a fraction of the cost of visits to laser hair clinics.
Rachel Namson [email protected] Tyler Barnett PR 8484 Wilshire Blvd, Beverly Hills, CA 90211 323.937.1951


China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 



